Congress of Clinical Rheumatology Annual Meeting

Healio brings you the highlights from Congress of Clinical Rheumatology annual meeting, and the accompanying North American Young Rheumatology Investigator Forum. Refer back to this page often for the latest news from CCR, perspectives and interviews with leading researchers and clinicians, and to review archives of past meetings.
Meeting News

Romosozumab at forefront of 'paradigm shift' in osteoporosis therapy

May 23, 2018
DESTIN, Fla. —Patients with osteoporosis treated with romosozumab demonstrated substantial gains in bone mineral density and T-score increases…
Meeting News

Rheumatic adverse effects of immune checkpoint therapy 'poorly recognized' in studies

May 22, 2018
DESTIN, Fla. — Although the incidence of rheumatologic adverse effects associated with immune checkpoint inhibitors is expected to grow with…
Meeting News

Disseminated intravascular coagulation linked to increased hospital deaths in Still's disease

May 22, 2018
DESTIN, Fla. — In-hospital deaths among patients with adult-onset Still’s disease was significantly higher among those with disseminated…
Meeting News

RA not a risk factor for CV mortality in ESRD

May 21, 2018
DESTIN, Fla. — Rheumatoid arthritis is not an independent risk factor for cardiovascular mortality in end stage renal disease, according to…
Meeting News

IgG4 serum insufficient to diagnose IgG4-related disease

May 21, 2018
DESTIN, Fla. —An over-reliance on elevations in serum immunoglobin G4 concentrations, or tissue immunoglobin G4-positive plasma cell numbers…
Meeting News

Weekly Actemra improves health-related quality of life, fatigue in GCA

May 20, 2018
DESTIN, Fla. — In patients with giant cell arteritis, a regimen of tocilizumab given 162 mg weekly plus a 26-week prednisone taper demonstrated…
Meeting News

GPA, PR3-ANCA predictors of vasculitis relapse

May 20, 2018
DESTIN, Fla. — Practical, individualized care for patients with antineutrophil cytoplasmic antibody-associated vasculitis should use the…
Meeting News

Lupus nephritis in first year of SLE predicts 'absolute worst' for patient

May 20, 2018
DESTIN, Fla. — Patients who develop lupus nephritis within their first year of being diagnosed with systemic lupus erythematosus have a 23.2%…
Meeting News

Stem cell transplant, Rituxan hold 'tremendous promise' for ILD with systemic sclerosis

May 19, 2018
DESTIN, Fla. — Stem cell transplantation, rituximab and tocilizumab show considerable promise as treatments for interstitial lung disease in…
Meeting News

Enbrel biosimilar demonstrates equivalent safety, efficacy in DMARD-refractory RA

May 19, 2018
DESTIN, Fla. — The etanercept biosimilar, etanercept-szzs, demonstrated an equivalent clinical efficacy and safety profile to etanercept among…